Daily FNArena News

Mesoblast has delivered positive results in animal testing of a compound for treating rheumatoid arthritis, though brokers concede further work needs to be done.

Update on share prices and consensus price targets. Today: are investors solely focusing on dividends?

Rising zinc stocks highlight weak market fundamentals, which offers the potential for further price weakness.

Woolworths delivered a solid Q4 sales result despite ongoing price deflation but brokers continue to see conditions for the retailer as challenging.

BIS Shrapnel’s 15-year forecast for the Australian economy sees a non-mining recovery as becoming the primary driver of growth.

FNArena’s weekly update on short positions in the Australian share market.

This week ATW’s Jerry Simmons takes a look at a broad range of technical indicators, with the AUDUSD and Comex Gold featuring prominently.

PFP Wealth Management’s Tim Price suggests along with debt issued by the most creditworthy sovereigns, investors should be looking at gold at current levels.

Another slow week in the uranium spot market sees the price slip a little further on very slim volumes.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Credit Suisse suggests Wilmar might be playing games with Goodman Fielder, impacting on market valuation.